A PHASE-II TRIAL OF RECOMBINANT ALPHA-2 INTERFERON (RIFN-ALPHA-2) IN RENAL-CELL CARCINOMA

被引：0
|
作者：
MUSS, HB
CAPONERA, M
COOPER, MR
HOPKINS, J
JACKSON, DV
ZEKAN, PJ
RICHARDS, F
STUART, JJ
SPURR, CL
WHITE, DR
GREINER, J
CAPIZZI, RL
SPIEGEL, RJ
NERI, R
机构：
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,ONCOL RES CTR,WINSTON SALEM,NC 27103
[2] SCHERING PLOUGH CORP,BLOOMFIELD,NJ 07003
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [21] TREATMENT OF PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERFERON-ALPHA-2B AND CONTINUOUS-INFUSION OF RECOMBINANT INTERLEUKIN-2 - A PHASE-II STUDY
    MORANT, R
    RICHNER, J
    AAPRO, M
    PALMER, PA
    SENN, HJ
    [J]. ONKOLOGIE, 1994, 17 (03): : 254 - 260
  • [22] INVITRO PHASE-II TRIAL OF RECOMBINANT INTERFERON-ALPHA-2 IN GASTROINTESTINAL CANCER
    SCHEITHAUER, W
    TEMSCH, EM
    SCHIEDER, K
    FUNOVICS, H
    SCHIESSEL, R
    GRABNER, G
    [J]. INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 188 - 198
  • [23] RECOMBINANT IFN-ALPHA-2 (RIFN-ALPHA-2) FOR TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BENIGN AND ACCELERATED PHASE
    GASTL, G
    AULITZKY, W
    TILG, H
    LUTTICHAU, I
    MICHLMAYR, G
    GADNER, H
    COSER, C
    SEEWANN, HL
    HUBER, H
    HUBER, C
    [J]. BLUT, 1987, 55 (04): : 387 - 387
  • [24] PHASE-II STUDY OF INTERFERON ALFA-2A, RECOMBINANT (ROFERON-A) IN METASTATIC RENAL-CELL CARCINOMA
    BUZAID, AC
    ROBERTONE, A
    KISALA, C
    SALMON, SE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (07) : 1083 - 1089
  • [25] RECOMBINANT IFN-ALPHA-2 (RIFN-ALPHA-2) FOR TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN BENIGN AND ACCELERATED PHASE
    GASTL, G
    AULITZKY, W
    TILG, H
    LUTTICHAU, I
    MICHLMAYR, G
    GADNER, H
    COSER, C
    SEEWANN, HL
    HUBER, H
    HUBER, C
    [J]. JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 737 - 737
  • [26] A PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALFA-2A IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    ILSON, DH
    MOTZER, RJ
    KRADIN, RL
    VOGELZANG, NJ
    BAJORIN, DF
    SCHER, HI
    NANUS, D
    OMOORE, P
    MARATHIAS, K
    BOSL, GJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1124 - 1130
  • [27] RESULTS OF A PHASE-II STUDY ON THE TREATMENT OF HAIRY-CELL LEUKEMIAS WITH DIFFERENT DOSES OF ALPHA-2 RECOMBINANT INTERFERON
    AULITZKY, W
    GASTL, G
    FLENER, R
    HUBER, C
    [J]. ACTA MEDICA AUSTRIACA, 1985, 12 : 1 - 2
  • [28] TREATMENT OF METASTATIC RENAL-CELL CARCINOMA WITH DAILY HIGH-DOSE OF ALPHA-2B INTERFERON - A PHASE-II STUDY
    CASCINU, S
    FEDELI, A
    FEDELI, SL
    CATALANO, G
    [J]. CANCER JOURNAL - FRANCE, 1991, 4 (06): : 388 - 390
  • [29] RECOMBINANT INTERFERON-ALPHA-2A AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    JURINCICWINKLER, C
    HORLBECK, R
    KLIPPEL, KF
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (10) : 271 - 276
  • [30] INTERFERON-ALPHA, 5-FU AND PREDNISONE IN METASTATIC RENAL-CELL CARCINOMA - A PHASE-II STUDY
    HAARSTAD, H
    JACOBSEN, AB
    SCHJOLSETH, SA
    RISBERG, T
    FOSSA, SD
    [J]. ANNALS OF ONCOLOGY, 1994, 5 (03) : 245 - 248
12345